Merck KGaA Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Merck KGaA şirketinin toplam hissedar öz sermayesi €28.4B ve toplam borcu €10.7B olup, bu da borç-öz sermaye oranını 37.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla €50.1B ve €21.7B dir. Merck KGaA 'in FAVÖK'ü €3.5B faiz karşılama oranı 95.4 dur. Şirketin €3.9B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

37.8%

Borç/özkaynak oranı

€10.74b

Borç

Faiz karşılama oranı	95.4x
Nakit	€3.86b
Eşitlik	€28.39b
Toplam yükümlülükler	€21.75b
Toplam varlıklar	€50.14b

Son finansal sağlık güncellemeleri

These 4 Measures Indicate That MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Using Debt Reasonably Well

Mar 26

We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Stay On Top Of Its Debt

Dec 12

Recent updates

Some Shareholders Feeling Restless Over Merck KGaA's (ETR:MRK) P/E Ratio

Oct 18

Is There An Opportunity With Merck KGaA's (ETR:MRK) 44% Undervaluation?

Sep 05

Here's Why Merck KGaA (ETR:MRK) Can Manage Its Debt Responsibly

Jul 24

Some Confidence Is Lacking In Merck KGaA's (ETR:MRK) P/E

Jul 03

Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 48% Above Its Share Price

May 22

Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20

Apr 26

Merck KGaA (ETR:MRK) Is Paying Out A Dividend Of €2.20

Apr 04

Merck KGaA (ETR:MRK) Has Affirmed Its Dividend Of €2.20

Mar 18

We Think Merck KGaA (ETR:MRK) Can Stay On Top Of Its Debt

Feb 07

There's Reason For Concern Over Merck KGaA's (ETR:MRK) Price

Jan 17

Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 77% Above Its Share Price

Dec 27

Does Merck KGaA (ETR:MRK) Have A Healthy Balance Sheet?

Oct 10

Is There An Opportunity With Merck KGaA's (ETR:MRK) 49% Undervaluation?

Sep 13

Is Merck KGaA (ETR:MRK) A Risky Investment?

Jun 30

Are Investors Undervaluing Merck KGaA (ETR:MRK) By 36%?

Jun 09

These 4 Measures Indicate That MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Using Debt Reasonably Well

Mar 26

MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Dividend Will Be Increased To €2.20

Mar 05

Estimating The Intrinsic Value Of MERCK Kommanditgesellschaft auf Aktien (ETR:MRK)

Feb 14

We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Stay On Top Of Its Debt

Dec 12

Is MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Trading At A 50% Discount?

Nov 09

Does MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Have A Healthy Balance Sheet?

Aug 15

Does MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Have A Healthy Balance Sheet?

May 17

MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Dividend Will Be Increased To €1.85

Mar 29

Is MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) A Risky Investment?

Jan 13

We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Manage Its Debt With Ease

Oct 15

A Look At The Intrinsic Value Of MERCK Kommanditgesellschaft auf Aktien (ETR:MRK)

Sep 19

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: MRK 'nin kısa vadeli varlıkları ( €13.9B ) kısa vadeli yükümlülüklerini ( €10.5B ) aşıyor.

Uzun Vadeli Yükümlülükler: MRK şirketinin kısa vadeli varlıkları ( €13.9B ) uzun vadeli yükümlülüklerini ( €11.3B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: MRK 'nin net borç/öz sermaye oranı ( 24.2% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: MRK 'nin borç/öz sermaye oranı son 5 yılda 69% seviyesinden 37.8% seviyesine düştü.

Borç Kapsamı: MRK 'nin borcu işletme nakit akışı ( 41% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: MRK 'in borcuna ilişkin faiz ödemeleri EBIT ( 95.4 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Merck KGaA Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Here's Why Merck KGaA (ETR:MRK) Can Manage Its Debt Responsibly

We Think Merck KGaA (ETR:MRK) Can Stay On Top Of Its Debt

Does Merck KGaA (ETR:MRK) Have A Healthy Balance Sheet?

Is Merck KGaA (ETR:MRK) A Risky Investment?

These 4 Measures Indicate That MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Using Debt Reasonably Well

We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Stay On Top Of Its Debt

Recent updates

Merck KGaA to Report Q4, 2024 Results on Mar 06, 2025

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Merck KGaA Announces Phase III Maneuver Trial of Pimicotinib

Merck KGaA (XTRA:MRK) completed the acquisition of Unity Semiconductor SAS for €160 million.

Some Shareholders Feeling Restless Over Merck KGaA's (ETR:MRK) P/E Ratio

Is There An Opportunity With Merck KGaA's (ETR:MRK) 44% Undervaluation?

Merck KGaA Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized Myasthenia Gravis (gMG)

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Here's Why Merck KGaA (ETR:MRK) Can Manage Its Debt Responsibly

Merck KGaA (XTRA:MRK) intends to acquire Unity Semiconductor SAS.

Merck KGaA (XTRA:MRK) intends to acquire Unity Semiconductor SAS.

Some Confidence Is Lacking In Merck KGaA's (ETR:MRK) P/E

Merck KGaA Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer

Merck KGaA Provides Updates on the Oncology Pipeline and Focused Approach to the Research and Development of Potential New Medicines Designed to Improve the Futures of Cancer Treatment

Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 48% Above Its Share Price

First quarter 2024 earnings: EPS exceeds analyst expectations

Merck KGaA, Annual General Meeting, Apr 25, 2025

Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20

Upcoming dividend of €2.20 per share

Merck KGaA (ETR:MRK) Is Paying Out A Dividend Of €2.20

Daiichi Sankyo and Merck Announce That the First Patient Has Been Dosed in the Rejoice-Ovarian01 Phase 2/3 Trial Evaluating the Efficacy and Safety of Investigational Raludotatug Deruxtecan (R-DXd) in Patients with Platinum-Resistant Ovarian Cancer

Merck KGaA (ETR:MRK) Has Affirmed Its Dividend Of €2.20

Dividend of €2.20 announced

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

We Think Merck KGaA (ETR:MRK) Can Stay On Top Of Its Debt

There's Reason For Concern Over Merck KGaA's (ETR:MRK) Price

Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 77% Above Its Share Price

Investor sentiment deteriorates as stock falls 15%

Merck Kgaa, Darmstadt, Germany Provides Update on Phase III Results for Evobrutinib in Relapsing Multiple Sclerosis

Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Merck KGaA to Report Q4, 2023 Results on Mar 07, 2024

Merck Receives Positive EU CHMP Opinion for PREVYMIS for Prevention of CMV Disease in High-Risk Adult Kidney Transplant Recipients and Extended 200-Day Dosing in Adult HSCT Recipients at Risk for Late CMV Infection and Disease

Does Merck KGaA (ETR:MRK) Have A Healthy Balance Sheet?

Is There An Opportunity With Merck KGaA's (ETR:MRK) 49% Undervaluation?

Second quarter 2023 earnings: Revenues exceed analyst expectations

Merck KGaA, Annual General Meeting, Apr 26, 2024

Is Merck KGaA (ETR:MRK) A Risky Investment?

Are Investors Undervaluing Merck KGaA (ETR:MRK) By 36%?

First quarter 2023 earnings: Revenues in line with analyst expectations

Merck Announces CFO Changes

Upcoming dividend of €2.20 per share at 1.3% yield

These 4 Measures Indicate That MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Using Debt Reasonably Well

MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Dividend Will Be Increased To €2.20

Full year 2022 earnings: Revenues in line with analyst expectations

Estimating The Intrinsic Value Of MERCK Kommanditgesellschaft auf Aktien (ETR:MRK)

Now 21% undervalued

Now 21% undervalued

Now 21% undervalued

We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Stay On Top Of Its Debt

Third quarter 2022 earnings: Revenues exceed analyst expectations

Merck Reportedly to Put Pigments Unit Up for Sale Again

MERCK Kommanditgesellschaft auf Aktien to Report Q4, 2022 Results on Mar 02, 2023

MERCK Kommanditgesellschaft auf Aktien Provides Earnings Guidance for the Full Year 2022

Is MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Trading At A 50% Discount?

Gerresheimer and Merck Transform Primary Packaging into Digital Twins

Does MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Have A Healthy Balance Sheet?

Second quarter 2022 earnings: Revenues exceed analyst expectations

Does MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Have A Healthy Balance Sheet?

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of €1.85 per share

MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Dividend Will Be Increased To €1.85

Full year 2021 earnings: Revenues in line with analyst expectations

MERCK Kommanditgesellschaft auf Aktien to Report Q2, 2022 Results on Aug 04, 2022

Is MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) A Risky Investment?

Third quarter 2021 earnings released

We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Manage Its Debt With Ease

A Look At The Intrinsic Value Of MERCK Kommanditgesellschaft auf Aktien (ETR:MRK)

Price target increased to €195